Abstract

BackgroundThere have been few reports on longitudinal change in activities of daily living (ADL), functional capacity, and life satisfaction in patients with subacute myelo-optico-neuropathy (SMON).MethodsA total of 1309 SMON patients 40 to 79 years of age underwent a medical examination conducted by the SMON Research Committee during the period from 1993 through 1995 (baseline) in Japan; 666 (51%) were followed-up after 12 years and were thus eligible for analysis. We calculated scores for ADL, functional capacity, and life satisfaction at baseline, and at 3, 6, 9, and 12 years after baseline, using data from medical examinations conducted in 1993 through 2007. The Barthel Index, the Tokyo Metropolitan Institute of Gerontology Index of Competence, and the patient’s response to the question “Are you satisfied with life?” were used to assess ADL, functional capacity, and life satisfaction, respectively.ResultsAs compared with baseline, the mean scores for ADL, functional capacity, and life satisfaction were all significantly lower after 12 years in men and women, with the exception of life satisfaction in women. The change in scores for functional capacity from baseline to year 12 was significantly associated with change in life satisfaction; however, the changes in ADL and age at baseline were not.ConclusionsWe observed decreases in ADL, functional capacity, and life satisfaction among SMON patients. Our results suggest that a decrease in life satisfaction can be prevented by maintaining or improving functional capacity.

Highlights

  • Subacute myelo-optico-neuropathy (SMON) is a disease caused by clioquinol intoxication and is characterized by subacute onset of sensory and motor disturbance in the lower extremities and visual impairment following abdominal symptoms.[1,2] In Japan, the incidence of subacute myelo-optico-neuropathy (SMON) peaked in the decade from 1960 to 1970.3,4 Currently, there are more than 2000 SMON patients, and they have a number of serious neurological symptoms.[4]Some studies have reported that activities of daily living (ADL) are limited in SMON patients due to their neurological symptoms.[4,5,6] In addition to ADL, functional capacity and life satisfaction are important in the lives of older SMON patients

  • In Japan, the incidence of SMON peaked in the decade from 1960 to 1970.3,4 Currently, there are more than 2000 SMON patients, and they have a number of serious neurological symptoms.[4]

  • We used crosssectional data from medical examinations of SMON patients conducted by the SMON Research Committee to analyze the distribution and associations of ADL, functional capacity, and life satisfaction.[8]

Read more

Summary

INTRODUCTION

Subacute myelo-optico-neuropathy (SMON) is a disease caused by clioquinol intoxication and is characterized by subacute onset of sensory and motor disturbance in the lower extremities and visual impairment following abdominal symptoms.[1,2] In Japan, the incidence of SMON peaked in the decade from 1960 to 1970.3,4 Currently, there are more than 2000 SMON patients, and they have a number of serious neurological symptoms.[4]. Some studies have reported that activities of daily living (ADL) are limited in SMON patients due to their neurological symptoms.[4,5,6] In addition to ADL, functional capacity and life satisfaction are important in the lives of older SMON patients. Functional capacity includes instrumental self-maintenance, intellectual activities, and social role.[6,7] In our previous report, we used crosssectional data from medical examinations of SMON patients conducted by the SMON Research Committee to analyze the distribution and associations of ADL, functional capacity, and life satisfaction.[8] there have been few studies on longitudinal change in ADL, and changes in functional capacity and life satisfaction have not been reported.[5]. We examine longitudinal change and associations of ADL, functional capacity, and life satisfaction in SMON patients, using follow-up data collected from 1993 through 2007

METHODS
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call